Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CMMB
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Chemomab Therapeutics Ltd. stock price down 0.155% on Wednesday
(Updated on Jul 03, 2024)

Sell candidate since Jun 28, 2024 Gain 6.04% PDF

The Chemomab Therapeutics Ltd. stock price fell by -0.155% on the last day (Wednesday, 3rd Jul 2024) from $0.97 to $0.97. During the last trading day the stock fluctuated 6.59% from a day low at $0.91 to a day high of $0.97. The price has fallen in 5 of the last 10 days but is still up by 2.06% over the past 2 weeks. Volume has increased on the last day by 10 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 15 thousand shares were bought and sold for approximately $14.95 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.92 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 39.50% during the next 3 months and, with a 90% probability hold a price between $1.28 and $1.97 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CMMB Signals & Forecast

There are few to no technical positive signals at the moment. The Chemomab Therapeutics Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.97 and $0.98. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 05, 2024, and so far it has fallen -25.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Chemomab Therapeutics Ltd. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Chemomab Therapeutics Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.89 and $0.85. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Chemomab Therapeutics Ltd. finds support just below today's level at $0.89. If this is broken, then the next support from accumulated volume will be at $0.85 and $0.85.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0600 between high and low, or 6.59%. For the last week, the stock has had daily average volatility of 7.83%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CMMB) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Chemomab Therapeutics Ltd. to open at $0.95, and during the day (based on 14 day Average True Range), to move between $0.87 and $1.07, which gives a possible trading interval of +/-$0.101 (+/-10.41%) up or down from last closing price. If Chemomab Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 20.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.89 (8.14%) than the resistance at $1.06 (9.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Chemomab Therapeutics Ltd. stock A Buy?

The Chemomab Therapeutics Ltd. stock holds several negative signals and despite the positive trend, we believe Chemomab Therapeutics Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.684 Sell Candidate Unchanged

Predicted Opening Price for Chemomab Therapeutics Ltd. of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$0.95 ( 1.89%) $0.97

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CMMB

Fibonacci Support & Resistance Levels

Level Price
R3 1.01 4.31%
R2 0.99 1.94%
R1 0.97 0.481%
Price 0.97
S1 0.93 -4.26%
S2 0.91 -5.72%
S3 0.89 -8.09%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.14 17.82%
R2 1.07 10.58%
R1 1.06 9.56%
Price 0.97
S1 0.89 -8.14%
S2 0.85 -11.86%
S3 0.85 -12.16%

FAQ

What is the symbol for Chemomab Therapeutics Ltd. Stock and on which exchange is it traded?
The symbol for Chemomab Therapeutics Ltd. is CMMB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Chemomab Therapeutics Ltd. Stock?
The Chemomab Therapeutics Ltd. stock holds several negative signals and despite the positive trend, we believe Chemomab Therapeutics Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Chemomab Therapeutics Ltd. Stock?
Chemomab Therapeutics Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Chemomab Therapeutics Ltd. Stock.

What's the current price of Chemomab Therapeutics Ltd. Stock?
As of the end of day on the Jul 03, 2024, the price of an Chemomab Therapeutics Ltd. (CMMB) share was $0.97.

What is the 52-week high and low for Chemomab Therapeutics Ltd. Stock?
The 52-week high for Chemomab Therapeutics Ltd. Stock is $1.50 and the 52-week low is $0.420.

What is the market capitalization of Chemomab Therapeutics Ltd. Stock?
As of the Jul 03, 2024, the market capitalization of Chemomab Therapeutics Ltd. is 13.757M.

When is the next earnings date for Chemomab Therapeutics Ltd.?
The upcoming earnings date for Chemomab Therapeutics Ltd. is Aug 12, 2024.
Click to get the best stock tips daily for free!

About Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd. Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and cha... CMMB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT